Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 673.79 million compared to CNY 700.18 million a year ago. Revenue was CNY 673.79 million compared to CNY 700.18 million a year ago.

Net income was CNY 270.15 million compared to CNY 327.22 million a year ago. Basic earnings per share from continuing operations was CNY 0.516 compared to CNY 0.625 a year ago. Diluted earnings per share from continuing operations was CNY 0.516 compared to CNY 0.625 a year ago.